Meg Tirrell

But anyway, in this situation, they came down.

And so the Trump administration negotiated a price of about $150 a month

The list price of these drugs was about $1,000 a month or more.

Significant drop.

And a lot of folks don't have good insurance coverage of these drugs.

A lot of insurance companies, even now, they're dropping coverage for weight loss of these medications.

And now you're hearing a lot of like...

examples of basically like PBMs or insurers saying, just buy it directly from the company.

Use cash pay.

So it's interesting that there's all these new ways of sort of paying for these drugs.

But $150 a month out of pocket, but it's only for the lowest doses of the medicines.

So most people start on this low dose, but then move up over time.

And so you're going to be paying more over time.

I think the highest price is around $350 a month, which is not insignificant.

It's a huge amount to be paying out of pocket.

but it is a lot lower than 1,000.

Yeah, I mean, I think what is cool about this is it can be seen as a trade-off between volume or the number of people you're helping.

Volume is the Wall Street word.

The number of people who can get access to these medicines versus how much each person is paying.

And if these are really so helpful, which the data suggests they are, then it's great that more people can get access to them and the companies can still make a total...